Previous Close | 1,403.60 |
Open | 1,404.60 |
Bid | 1,380.00 x 0 |
Ask | 1,495.00 x 0 |
Day's Range | 1,399.83 - 1,416.20 |
52 Week Range | 1,280.92 - 2,746.59 |
Volume | |
Avg. Volume | 9,417,546 |
Market Cap | 70.707B |
Beta (5Y Monthly) | 0.29 |
PE Ratio (TTM) | 13.49 |
EPS (TTM) | 104.20 |
Earnings Date | Feb 01, 2023 |
Forward Dividend & Yield | 0.86 (6.18%) |
Ex-Dividend Date | Aug 18, 2022 |
1y Target Est | N/A |
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UK public borrowing increased by more than expected last month as the government ploughed billions into its subsidies for household bills.
The experimental respiratory syncytial virus vaccine prevented most infections in older adults in a Phase 3 clinical trial